These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Comparative outcomes of cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective multicentre cohort study in Korea. Lee S, Song KH, Jung SI, Park WB, Lee SH, Kim YS, Kwak YG, Kim YK, Kiem SM, Kim HI, Kim ES, Park KH, Kim NJ, Jang HC, Kim HB, Korea INfectious Diseases (KIND) study group. Clin Microbiol Infect; 2018 Feb; 24(2):152-158. PubMed ID: 28694202 [Abstract] [Full Text] [Related]
17. Retrospective Analysis of Adverse Drug Events Between Nafcillin Versus Cefazolin for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections. Chan L, Chan-Tompkins NH, Como J, Guarascio AJ. Ann Pharmacother; 2020 Jul; 54(7):662-668. PubMed ID: 31888347 [Abstract] [Full Text] [Related]